LINAGLIPTIN Pharmacologic Class Indexing
- Class set ID
- 04280b40-e737-44bb-b25d-ff5f8eb231be
- Version
- 2
- Effective date
- 20180813
- Type
- Indexing - Pharmacologic Class
Mapped DailyMed Labels#
Label, Manufacturer, Effective table| Label | Manufacturer | Effective | SPL version |
|---|
| These highlights do not include all the information needed to use TRIJARDY XR safely and effectively. See full prescribing information for TRIJARDY XR. TRIJARDY ® XR (empagliflozin, linagliptin, and metformin hydrochloride extended-release tablets), for oral use Initial U.S. Approval: 2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | 20260130 | 10 |
| These highlights do not include all the information needed to use GLYXAMBI safely and effectively. See full prescribing information for GLYXAMBI. GLYXAMBI ® (empagliflozin and linagliptin tablets), for oral use Initial U.S. Approval: 2015 | Boehringer Ingelheim Pharmaceuticals, Inc. | Boehringer Ingelheim Pharma GmbH and Co. KG | Sixarp, LLC | Rottendorf Pharma GmbH | 20260120 | 23 |
| These highlights do not include all the information needed to use LINAGLIPTIN TABLETS safely and effectively. See full prescribing information for LINAGLIPTIN TABLETS. LINAGLIPTIN tablets, for oral use Initial U.S. Approval: 2011 | Sunshine Lake Pharma Co., Ltd. | 20260114 | 6 |
| These highlights do not include all the information needed to use LINAGLIPTIN and METFORMIN HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for LINAGLIPTIN and METFORMIN HYDROCHLORIDE TABLETS. LINAGLIPTIN and METFORMIN HYDROCHLORIDE tablets, for oral use Initial U.S. Approval: 2012 | Novadoz Pharmaceuticals LLC | MSN LABORATORIES PRIVATE LIMITED | 20251104 | 1 |
| These highlights do not include all the information needed to use TRADJENTA safely and effectively. See full prescribing information for TRADJENTA. TRADJENTA ® (linagliptin tablets), for oral use Initial U.S. Approval: 2011 | Cardinal Health 107, LLC | 20250827 | 12 |
| These highlights do not include all the information needed to use TRADJENTA safely and effectively. See full prescribing information for TRADJENTA. TRADJENTA ® (linagliptin tablets), for oral use Initial U.S. Approval: 2011 | Boehringer Ingelheim Pharmaceuticals, Inc. | Boehringer Ingelheim Pharma GmbH and Co. KG | West-Ward Columbus Inc. | Boehringer Ingelheim Promeco, S.A. de C.V. | Sixarp, LLC | Bidachem S.p.a. | 20250321 | 32 |
| These highlights do not include all the information needed to use JENTADUETO safely and effectively. See full prescribing information for JENTADUETO. JENTADUETO ® (linagliptin and metformin hydrochloride tablets), for oral use Initial U.S. Approval: 2012 | Boehringer Ingelheim Pharmaceuticals, Inc. | Boehringer Ingelheim Pharma GmbH and Co. KG | Boehringer Ingelheim Promeco S.A. de C.V. | VISTIN Pharma AS | Sixarp, LLC | 20240627 | 45 |
| These highlights do not include all the information needed to use JENTADUETO XR safely and effectively. See full prescribing information for JENTADUETO XR. JENTADUETO ® XR (linagliptin and metformin hydrochloride extended-release tablets), for oral use Initial U.S. Approval: 2012 | Boehringer Ingelheim Pharmaceuticals, Inc. | Patheon Pharmaceuticals Inc. | Sixarp, LLC | 20240524 | 9 |
| These highlights do not include all the information needed to use TRADJENTA safely and effectively. See full prescribing information for TRADJENTA. TRADJENTA ® (linagliptin tablets), for oral use Initial U.S. Approval: 2011 | A-S Medication Solutions | 20240122 | 8 |
| These highlights do not include all the information needed to use JENTADUETO safely and effectively. See full prescribing information for JENTADUETO. Jentadueto ® (linagliptin and metformin hydrochloride) tablets Initial U.S. Approval: 2012 | Physicians Total Care, Inc. | 20150506 | 2 |